MODV

MODV

USD

ModivCare Inc. Common Stock

$1.460+0.030 (2.098%)

वास्तविक समय मूल्य

Healthcare
Medical Care Facilities
संयुक्त राज्य अमेरिका

मूल्य चार्ट

Loading Chart...

मुख्य मीट्रिक्स

बाजार मीट्रिक्स
कंपनी के मौलिक सिद्धांत
ट्रेडिंग आँकड़े

बाजार मीट्रिक्स

खुलना

$1.430

उच्च

$1.530

कम

$1.321

मात्रा

0.04M

कंपनी के मौलिक सिद्धांत

बाजार पूंजीकरण

20.9M

उद्योग

Medical Care Facilities

देश

United States

ट्रेडिंग आँकड़े

औसत मात्रा

0.50M

एक्सचेंज

NMS

मुद्रा

USD

52-सप्ताह रेंज

कम $0.96वर्तमान $1.460उच्च $32.82

AI विश्लेषण रिपोर्ट

अंतिम अपडेट: 2 मई 2025
AI-जनितडेटा स्रोत: Yahoo Finance, Bloomberg, SEC

MODV (ModivCare Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: MODV Generate Date: 2025-05-02 17:25:32

Alright, let's break down what's been happening with ModivCare stock lately, looking at the news, how the price has moved, and what some predictions are saying. Think of this as getting the lowdown on the situation.

Recent News Buzz: A Mixed Bag

Looking at the latest headlines, it's a bit of a mixed picture for ModivCare.

On the positive side, the company recently announced a partnership with Aetna in Illinois to launch "Health Stations." This sounds like a step towards expanding their services and making healthcare access easier, which is generally good news for the business itself. They also made changes to their Board of Directors, bringing in an executive with finance and governance experience. That often signals a move to strengthen leadership and potentially improve how the company is run.

However, there's also news about a law office investigating claims on behalf of long-term shareholders. This kind of news is definitely a negative signal. It suggests there might be underlying issues or concerns that could potentially lead to legal trouble or shareholder disputes down the road.

Finally, there's the standard announcement about reporting their first quarter 2025 financial results soon. This isn't positive or negative on its own, but it's a big event coming up. The actual results will be a major factor in how the stock moves next.

So, the news flow gives us some positive business developments and board strengthening, but also a clear red flag with the shareholder investigation.

Price Check: A Wild Ride, Then a Bounce

Now, let's look at the stock price itself over the past few months. It's been quite volatile.

Back in early February, the stock was trading around the $3.50 to $4.00 range. It saw a pretty strong run-up through February, even hitting highs around $6.00. But after that peak, things took a sharp turn downwards. The price fell significantly and pretty consistently through March and into April, dropping all the way down to around the $1.00 mark. That's a massive decline in a relatively short time.

More recently, though, the picture has changed a bit. Since hitting those lows in mid-April, the stock has bounced back. We've seen the price climb from around $1.00-$1.10 up to the current level, which is sitting around $1.52. There was a noticeable jump in price and volume around April 23rd and 24th.

Comparing the current price ($1.52) to the AI's short-term predictions, the AI sees a slight dip today and tomorrow (-1.05% and -0.08%), followed by a small gain the day after (+0.80%). These predictions suggest the AI doesn't expect huge moves in the immediate future, at least not based on its model.

Putting It Together: Outlook & Ideas

So, what does all this suggest? We have mixed news, a stock price that crashed hard but is now showing signs of life with a recent bounce, and AI predictions that are pretty flat for the next couple of days.

Based on this mix, the near-term picture is complicated. The recent price bounce could be the start of a recovery or just a temporary relief rally after a big fall. The positive news about partnerships and the board is encouraging for the company's operations, but the shareholder investigation adds a layer of risk and uncertainty. The upcoming earnings report is the next big unknown that could swing things significantly.

However, looking at the additional recommendation data provided, it points to some strong technical signals right now, like a surge in trading volume and a bullish crossover in a technical indicator called MACD. It also highlights the company's very low P/E ratio (around 0.5x), suggesting it might be significantly undervalued compared to its industry peers, despite some fundamental weaknesses like negative revenue growth and return on equity. This combination of bullish technicals and potential value is interesting.

Potential Strategy Ideas (Thinking Out Loud):

  • Considering Entry: If someone were looking at this stock based on the recent bounce and the bullish technical/value signals mentioned in the recommendation data, they might consider potential entry points. The recommendation data specifically suggested levels around $1.34 to $1.38. The current price is above that, so one approach could be to wait and see if the price dips back towards that range. However, sometimes momentum keeps going, so that's a trade-off.
  • Managing Risk: Given the stock's history of sharp declines and the uncertainty from the news (especially the investigation and upcoming earnings), managing risk is crucial. The recommendation data suggests a potential stop-loss level around $1.24. This is below the recent bounce area and could serve as a point to consider exiting if the price starts falling significantly again, helping to limit potential losses. Setting a stop-loss is a common way to protect yourself in volatile stocks like this one has proven to be.
  • Potential Exit: The recommendation data mentioned a take-profit around $1.40, which is below the current price – that doesn't quite line up with a bullish view from here. Instead of relying on that specific number, if the price continues to climb, potential exit points might be considered around recent highs or levels where the price struggled before its big fall. But honestly, with the volatility, just having a clear stop-loss might be the most important thing to think about for risk control.

Company Context

Just to quickly remember what ModivCare does: they're in the healthcare services business, focusing on things like non-emergency medical transportation, personal care at home, and monitoring services. They work a lot with government programs like Medicaid and Medicare. The company is relatively small with a market cap around $21.7 million, which is part of why its stock price can swing so wildly. The extremely low P/E ratio (0.5x) stands out, but it's balanced by concerning fundamental numbers like the negative Return on Equity (-342%). This tells you there's a complex financial picture under the hood.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves significant risk, and you could lose money. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

संबंधित समाचार

BusinessWire

Modivcare to Report First Quarter 2025 Financial Results

Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today

और देखें
Modivcare to Report First Quarter 2025 Financial Results
BusinessWire

Modivcare Announces Changes to Board of Directors

Seasoned Executive Daniel Silvers Brings Decades of Experience in Corporate Finance, Capital Allocation and Public Company Governance Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled

और देखें
Modivcare Announces Changes to Board of Directors
BusinessWire

Modivcare and Aetna Better Health® of Illinois Transform Access to Healthcare in Illinois with Launch of Health Stations

Illinoisans now have easy access to user friendly enhanced health stations through a collaboration between Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a healthcare services company integrating

और देखें
Modivcare and Aetna Better Health® of Illinois Transform Access to Healthcare in Illinois with Launch of Health Stations
GlobeNewswire

Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR) - Grabar Law Office Is Investigating Claims on Your Behalf

PHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (NASDAQ:KYTX): Grabar Law Office is investigating claims on behalf of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) shareholders. The

और देखें
Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR) - Grabar Law Office Is Investigating Claims on Your Behalf

AI भविष्यवाणीBeta

AI सिफारिश

मंदी

पर अपडेट किया गया: 4 मई 2025, 06:03 pm

मंदीतटस्थतेजी

58.8% आत्मविश्वास

जोखिम और ट्रेडिंग

जोखिम स्तर3/5
मध्यम जोखिम
के लिए उपयुक्त
मूल्य
ट्रेडिंग गाइड

प्रवेश बिंदु

$1.45

लाभ लें

$1.56

स्टॉप लॉस

$1.31

मुख्य कारक

डीएमआई मंदी की प्रवृत्ति दिखाता है (ADX:14.9, +DI:22.3, -DI:26.8), सावधानी बरतने का सुझाव देता है
वर्तमान मूल्य समर्थन स्तर (1.46 $) के बेहद करीब है, जो मजबूत खरीद अवसर का सुझाव देता है
ट्रेडिंग वॉल्यूम औसत (6,480) का 4.2 गुना है, जो बेहद मजबूत खरीदारी दबाव का संकेत देता है
एमएसीडी -0.0066 सिग्नल लाइन -0.0056 से नीचे है, जो मंदी के क्रॉसओवर का संकेत देता है

अपडेट रहें

मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।